New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base;   - concentrate for injection - 1 mg/ml - active: noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base   excipient: nitrogen sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusions and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - noradrenaline acid tartrate monohydrate 2 mg/ml equivalent to noradrenaline base 1 mg/ml - concentrate for injection - 1 mg/ml - active: noradrenaline acid tartrate monohydrate 2 mg/ml equivalent to noradrenaline base 1 mg/ml excipient: sodium chloride sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusions and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 8mg/8ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 2mg/2ml solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.239 mg/ml equivalent to 0.12 mg/ml noradrenaline base;   - solution for infusion - 0.12 mg/ml - active: noradrenaline acid tartrate monohydrate 0.239 mg/ml equivalent to 0.12 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base;   - solution for infusion - 0.06 mg/ml - active: noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base - solution for infusion - 0.08 mg/ml - active: noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.319 mg/ml equivalent to 0.16 mg/ml noradrenaline base;   - solution for infusion - 0.16 mg/ml - active: noradrenaline acid tartrate monohydrate 0.319 mg/ml equivalent to 0.16 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).